Analysis 5.3.
Comparison 5 Liraglutide 0.6 mg daily versus placebo, Outcome 3 Hypoglycaemia rate (events/patient‐year).
Hypoglycaemia rate (events/patient‐year)
| Study | Liraglutide 0.6 mg daily | Placebo |
|---|---|---|
| L ‐ Kaku 2010 | 2.17 | 1.01 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.